4//SEC Filing
Ragan Paula 4
Accession 0001628280-23-020355
CIK 0001501697other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 5:05 PM ET
Size
5.4 KB
Accession
0001628280-23-020355
Insider Transaction Report
Form 4
Ragan Paula
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2023-05-31$1.95/sh−6,292$12,269→ 557,245 total
Footnotes (3)
- [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.90 to $2.01, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Of the shares of common stock reported, 188,492 shares represent unvested restricted stock units.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001769914
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 5:05 PM ET
- Size
- 5.4 KB